First Responder Initiative “Dialed & Defend” to Provide Fire Stations Across California with Saunas Launches Dec. 14 at Event in Newport Beach, CA
Organization founded by sauna manufacturer Dialed Labs; company makes initial donation of $250,000 –(BUSINESS WIRE)–Dialed & Defend: WHAT: The official... Read more.
Brighton Marine Announces New Leadership for Health Plan Operations, Real Estate & Housing, and Pharmacy Services
BOSTON–(BUSINESS WIRE)–Brighton Marine appoints three senior leaders to drive key business units serving veterans, military families, and communities... Read more.
Matter Health Appoints Michael Scarbrough as Chief Executive Officer
Founder & CEO Mason Mercy to Transition to President/Chief Strategy Officer as Matter Health Strengthens Leadership for National Expansion to meet rising demand... Read more.
Anthem Blue Cross and Blue Shield Donates Over $60,000 to Support Holiday Food Distributions Across New York
More than 6,400 bags of fresh produce and food items will be distributed at Anthem Community Service Centers NEW YORK–(BUSINESS WIRE)–Anthem Blue Cross... Read more.
BTDR Investors Have Opportunity to Lead Bitdeer Technologies Group Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$BTDR—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
CHS Owners Elect Five Directors to CHS Board
SAINT PAUL, Minn.–(BUSINESS WIRE)–Owners of CHS, a global agribusiness and the nation’s leading cooperative, elected five board members to three-year... Read more.
Superior Industries Announces Closing of Acquisition by a Group of Existing Term Loan Investors
Transaction strengthens balance sheet, positions Superior for long-term growth SOUTHFIELD, Mich.–(BUSINESS WIRE)–Superior Industries International, Inc.... Read more.
Aleta Biotherapeutics and Cancer Research UK Announce Promising Phase I/II Data from ALETA-001 Clinical Trial for Patients With Relapsed/Refractory B-Cell Malignancies Previously Treated with CD19 CAR T-Cell Therapy
The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of Aleta’s first-in-class biologic CAR T-cell engager,... Read more.
Orca Bio Presents New Clinical Data on its Pipeline of High-Precision Cell Therapies including Orca-Q® Without GvHD Prophylaxis and Orca-T/CAR-T Combination Therapy at the 67th ASH Annual Meeting
Orca-Q, Orca Bio’s second investigational allogeneic T-cell immunotherapy, showed low rates of acute and chronic GvHD, infections and non-relapse mortality with... Read more.
Tachyum Defends TPU® Trademark from Infringement by Google TPU
LAS VEGAS–(BUSINESS WIRE)–#Linux—Tachyum® today announced that it is beginning to take steps to defend the use of its registered TPU® trademark.... Read more.